Clinical Report: Cardiovascular Implications in Ankylosing Spondylitis
Overview
Ankylosing spondylitis (AS) and axial spondyloarthritis (axSpA) significantly increase cardiovascular risk, leading to major adverse events such as myocardial infarction and stroke. This report highlights the need for integrated management strategies that address both inflammatory control and cardiovascular risk assessment.
Background
AS and axSpA are chronic inflammatory diseases primarily affecting the axial skeleton, with systemic implications that extend to cardiovascular health. The recognition of increased cardiovascular risk in these patients is crucial, as it can significantly influence long-term outcomes. Understanding the interplay between systemic inflammation and cardiovascular injury is essential for improving patient management.
Data Highlights
No specific numerical data or trial results were provided in the source material.
Key Findings
Patients with AS/axSpA exhibit increased risks of myocardial infarction, stroke, and atrial fibrillation.
Subclinical vascular abnormalities, such as endothelial dysfunction and arterial stiffness, are common in these patients.
Inflammatory pathways involving TNF, IL-17, and IL-6 contribute to cardiovascular injury.
Tumor necrosis factor inhibitors may offer cardiovascular benefits by controlling inflammation.
Patients with high inflammatory activity or extra-articular manifestations have a particularly elevated cardiovascular risk.
Clinical Implications
Healthcare providers should incorporate cardiovascular risk assessment into the management of AS/axSpA patients. This includes monitoring for traditional risk factors and considering the cardiovascular effects of various treatment options, particularly in patients with high inflammatory activity.
Conclusion
The cardiovascular implications of AS and axSpA necessitate a comprehensive approach to patient care that integrates disease management with cardiovascular risk evaluation. Ongoing surveillance and proactive strategies are essential for improving patient outcomes.
So get this: sodium may track with memory decline (in men), steroids might not be “immunosuppressive” in the ICU, and second pregnancies reshape the brain differently than first. Same theme: biology is less binary than we teach it.
